Neuromuscular

National Online Directory of Amyotrophic Lateral Sclerosis Specialists Launched

Monday, February 04, 2019—A national online database of healthcare providers (HCPs) who treat amyotrophic lateral sclerosis (ALS) has been launched by Mitsubishi Tanabe Pharma America (MTPA). The …

Hometown Highlights: Congenital Myasthenic Syndromes

Andrew G. Engel, MD

February 2019—With careful diagnosis, treatment can improve symptoms of congenital myasthenic syndromes.

Neuromuscular Community Survey Identifies Key Issues

Thursday, January 17, 2019—The Muscular Dystrophy Association (MDA) has announced results of a landmark survey that asked more than 3,000 people affected by neuromuscular disease (NMD) about their key a…

Phase 3 Trial of Dioscorea japonica Extracts To Be Initiated for Treatment of Pain From Diabetic Neuropathy

Tuesday, January 08, 2019—The planned initiation of a phase 3 double-blind, placebo controlled, 12-week study of Dioscorea japonica extracts (NB-01; Neurobo, Boston, MA) for pain relief in pa…

2018 Drug and Device Approvals for Neurology

January 2019—HEADACHE & PAIN Noninvasive Vagus Nerve Stimulation (Gammacore; electroCore, Basking Ridge, NJ) Cleared: November 28, 2018 and January 29, 2018 Indications: adjun…

Cognitive Complaints and Neuropsychologic Testing

Nabil Ali, MD; Kendra Corning, PsyD, HSPP; and Laura M. Clark, PhD, ABPP

January 2019—When should neuropsychologic tests be ordered and what questions should testing answer?

American Academy of Neurology Call for Uniformity in Brain Death Standards

Thursday, January 03, 2019—Noting that only 1 state, Nevada, has adopted legislation requiring use of medically accepted guidelines for determining brain death, the American Academy of Neurology (AAN) i…

Reliability of Ultrasound Measurements in Patients with Amyotrophic Lateral Sclerosis

Friday, December 28, 2018—In a study published in the journal Muscle & Nerve, researchers suggest diagnostic ultrasound may provide a reliable biomarker for amyotrophic lateral scle